Scott Gottlieb

Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) soared higher by more than 25 percent on Tuesday in reaction to the company's announcement that there is now a clear path to approval for its migalastat NDA therapy. Amicus suffered a major setback for its therapy in November, 2016 when the U.S....

Sources close to President-elect Donald Trump’s transition team have revealed that Dr. Scott Gottlieb could be the next head of the U.S. Food and Drug Administration (FDA). Jim O'Neill is also being considered for the position, several media outlets have previously reported. All About...